Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Isomorphic Labs sets up US presence in Cambridge, with an eye on clinical trials By Katie Palmer STAT,Updated June 17, 2025, 10:57 a.m.

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

Isomorphic Labs, together with Google DeepMind, developed and released AlphaFold 3 in May 2024, a revolutionary AI model that can predict the structure and interactions of all of life's molecules ...

China has launched a controversial new civilian flight path near Taiwan, saying the route will reduce air traffic congestion.

Isomorphic Labs sets up U.S. presence, with an eye on clinical trials The Alphabet company, spun off from DeepMind, is hiring a new chief medical officer and adding an office in Cambridge ...

Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...

When Demis Hassabis, chief executive officer of DeepMind Technologies, posted an announcement about the collaboration between Eli Lilly, Novartis, and Google DeepMind’s spin-off Isomorphic Labs ...

It follows shortly after another Alphabet start-up, Isomorphic Labs, announced its first pharma partnerships with Eli Lilly and Novartis, collectively worth almost $3 billion and focused on the ...

Isomorphic Labs, an AI-first drug discovery company, has announced the appointment of Ben B. Wolf as chief medical officer. Dr. Wolf will be based in the company's newly established Cambridge location ...